| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |